v3.26.1
Segment Disclosures (Details)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
USD ($)
Mar. 31, 2026
USD ($)
Jun. 30, 2025
USD ($)
Mar. 31, 2025
USD ($)
Jun. 30, 2026
USD ($)
segment
Jun. 30, 2025
USD ($)
Segment Disclosures            
Number of reportable segments | segment         1  
Total revenue $ 88   $ 836   $ 198 $ 1,704
Cost of product revenues 25   46   57 90
Depreciation and amortization expense         186 164
Interest expense (income), net 1,768   36   2,589 (130)
Net loss (23,755) $ (20,691) (19,363) $ (18,755) (44,446) (38,118)
Partnership revenue            
Segment Disclosures            
Total revenue     667     1,399
Product revenue            
Segment Disclosures            
Total revenue 88   169   198 305
Single Reportable Segment            
Segment Disclosures            
Cost of product revenues 25   46   57 90
Personnel and consulting costs 8,823   7,002   17,611 13,666
Stock-based compensation 2,505   3,250   5,356 6,215
Depreciation and amortization expense 96   81   186 164
Other segment expenses $ 2,287   $ 2,544   $ 2,882 $ 5,170
Segment Reporting, Other Segment Item, Composition, Description Other segment expenses primarily include the gain on the sale of strategic investments as well as general and administrative costs not presented in other line items   Other segment expenses primarily include the gain on the sale of strategic investments as well as general and administrative costs not presented in other line items   Other segment expenses primarily include the gain on the sale of strategic investments as well as general and administrative costs not presented in other line items Other segment expenses primarily include the gain on the sale of strategic investments as well as general and administrative costs not presented in other line items
Interest expense (income), net $ 1,768   $ 36   $ 2,589 $ (130)
Net loss (23,755)   (19,363)   (44,446) (38,118)
Single Reportable Segment | Partnership revenue            
Segment Disclosures            
Total revenue     667     1,399
Single Reportable Segment | Product revenue            
Segment Disclosures            
Total revenue 88   169   198 305
Single Reportable Segment | Non-clinical development costs            
Segment Disclosures            
Development costs 3,379   4,607   7,429 9,072
Single Reportable Segment | Clinical development costs            
Segment Disclosures            
Development costs $ 4,960   $ 2,633   $ 8,534 $ 5,575